Hercules Capital Related Content

Hercules Capital Provides $115MM Loan Facility to X4 Pharmaceuticals

X4 Pharmaceuticals, a provider and developer of novel small-molecule therapeutics to benefit people with rare diseases of the immune system, closed a $115 million loan facility with Hercules Capital. read more

Hercules Capital Appoints Bluestein Permanent CEO & President

Hercules Capital named Scott Bluestein chief executive officer and president and elected him to the company’s Board of Directors. Bluestein has served as interim CEO since March 2019. read more

Hercules Capital CEO Steps Down After Charge in College Admissions Scheme

Hercules Capital CEO Manuel Henriquez has voluntarily stepped aside as the firm’s chairman and CEO. According to Bloomberg, the news comes in the wake of Henriquez’s indictment by federal authorities because of his alleged involvement in the college admissions cheating scandal. read more

Hercules Capital Completes $250 Million Securitization

Hercules Capital Funding Trust 2019-1, an indirect subsidiary of Hercules Capital, issued $250 million in class A notes rated A(sf) by KBRA, backed by approximately $357.2 million of senior secured loans. read more

View Latest Digital Edition

Terry Mulreany
Subscriptions: 800 708 9373 x130
[email protected]
Susie Angelucci
Advertising: 484.459.3016
[email protected]

View Latest Digital Edition

Visit our sister website for news, information, exclusive articles,
deal tables and more on the asset-based lending, factoring,
and restructuring industries.